Results 61 to 70 of about 102,651 (313)

Therapeutic Management of Septic Venous Thrombosis: A Narrative Review

open access: yesInfectious Disease Reports
Background/Objectives: Septic venous thrombosis is an uncommon complication but clinically significant due to its high morbidity and mortality and the complexity of therapeutic decision-making. The lack of standardized guidelines and the scarcity of high-
Anabel Franco-Moreno   +3 more
doaj   +1 more source

Forty-One-Year-Old Man with Pulmonary Embolism 5 Months After COVID-19

open access: yesClinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2021
Background: Hypercoagulation is one of the striking features of COVID-19. Patients hospitalized with COVID-19 are at high risk for venous thromboembolism. However, it is unknown if the risk for venous thromboembolism persists after discharge.
Muhanad Taha   +4 more
doaj   +1 more source

Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review. [PDF]

open access: yes, 2019
BACKGROUND Vitamin K antagonists (VKA) are the most widely used anticoagulants, and bridging is commonly administered during periprocedural VKA interruption.
Whitaker, Evans   +3 more
core   +1 more source

The Outrigger Technique for Medial Opening Wedge High Tibial Osteotomy Using a Hintermann Distractor to Control the Osteotomy Gap Opening and the Posterior Tibial Slope

open access: yesArthroscopy Techniques, EarlyView.
Abstract Medial opening wedge high tibial osteotomy is a successful procedure for correction of varus malalignment in isolation or in combination with other knee ligamentous and cartilage procedures. This article describes a technique for medial opening wedge high tibial osteotomy using a Hintermann distractor, which allows better control of the ...
Sam Yasen, Ahmed Mabrouk
wiley   +1 more source

High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromsø study

open access: yesHaematologica, 2011
Background High-sensitivity C-reactive protein is associated with risk of arterial cardiovascular disease but conflicting results have been reported on its role in venous thromboembolic disease.
Erin M. Hald   +6 more
doaj   +1 more source

A prospective series of acute rivaroxaban overdose, coagulopathy and bleeding complications (ATOM 11)

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim There is limited research describing rivaroxaban overdose. We aim to describe rivaroxaban overdose, coagulopathy and bleeding complications. Methods This is a prospective series of acute adult (>14 years) rivaroxaban overdose presentations >40 mg enrolled in the Australian Toxicology Monitoring study and presenting to three Australian clinical ...
Katherine Z. Isoardi   +3 more
wiley   +1 more source

Effects of Hyperthyroidism on Venous Thromboembolism: A Mendelian Randomization Study

open access: yesJournal of Immunology Research, 2022
Objective. Observational studies show the correlation between thyroid dysfunction and risk of venous thromboembolism. However, the causal effects remain uncertain. Our study was conducted to evaluate whether thyroid function and dysfunction were causally
Fushi Han   +5 more
doaj   +1 more source

ABO(H) blood groups and vascular disease: a systematic review and meta-analysis [PDF]

open access: yes, 2008
<i>Background</i>: Associations between vascular disease and ABO(H) blood groups have a long history, but no consensus exists regarding its magnitude and significance, or whether it relates to all disorders equally. An accurate calculation of
O. WU   +7 more
core   +1 more source

Risk of venous thromboembolism after SARS‐CoV‐2 vaccination—Evidence from genome‐wide association study and population‐based observational study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim We aimed to investigate whether genetic variation is associated with venous thromboembolism after immunization with SARS‐CoV‐2 vaccines. Methods We conducted a genome‐wide association study (GWAS) on cases of venous thromboembolism within 42 days after SARS‐CoV‐2 vaccination, recruited from reports of adverse drug reactions sent to the Swedish ...
Sofia Attelind   +7 more
wiley   +1 more source

Reliability and validity of Risk Assessment Scale for Perinatal Venous Thromboembolism in parturients

open access: yesHuli yanjiu, 2022
ObjectiveTo test reliability and validity of Risk Assessment Scale for Perinatal Venous Thromboembolism in parturients.Methods230 parturients who were hospitalized in obstetric ward of the International Peace Maternity and Child Health Hospital,School of
ZHAN Zhuang, GONG Wenyan
doaj  

Home - About - Disclaimer - Privacy